Your browser doesn't support javascript.
loading
Implementation of the European Society of Cardiology 0/3-hour accelerated diagnostic protocol, using high sensitive troponin T: a clinical practice evaluation of safety and effectiveness involving 3003 patients with suspected acute coronary syndrome.
Hatherley, James Daniel; Salmon, Thomas; Collinson, Paul O; Khand, Aleem.
Afiliação
  • Hatherley JD; Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool, UK.
  • Salmon T; Department of Cardiology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
  • Collinson PO; Department of Cardiology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Khand A; Clinical Blood Sciences, St George's University Hospitals NHS Foundation Trust, London, UK.
Open Heart ; 10(2)2023 Dec 26.
Article em En | MEDLINE | ID: mdl-38151261
ABSTRACT

BACKGROUND:

There have been relatively few studies detailing the real-world effectiveness and safety of accelerated diagnostic protocols (ADP), using high sensitivity cardiac troponin (hs-cTn).

OBJECTIVE:

To analyse the safety and effectiveness of early emergency department (ED) discharge following implementation of the European Society of Cardiology (ESC) 0/3-hour ADP for suspected acute coronary syndromes (ACS).

METHOD:

We prospectively studied 2 cohorts of consecutive suspected ACS presentations to ED before (n=1642) and after (n=1376, 2 centres) implementation of the ESC 0/3-hour ADP incorporating limit of detection rule out. Safety was defined by MACE (major adverse cardiac events) inclusive of type 1 myocardial infarction (MI) in patients discharged from ED, and clinical effectiveness by percentage ED discharge. Continuous variables and categorical data were evaluated by independent t-test and χ2 test, respectively. Time-to-event data were analysed as survival data and converted to Kaplan-Meier curves for interpretation.

RESULTS:

In the preimplementation period, there was a higher prevalence of MI. Discharge from ED increased by >100% (from 27.1% to 56.5% of the cohort) with no safety signal (MACE rate 4/444 (0.9%) vs 4/769 (0.52%), p=0.430 for the 2011 and 2018 cohort, respectively). This correlated with a marked reduction in length of stay overall but a more modest reduction for those discharged from ED (6 hours 10 min vs 5 hours 25 min, p<0.001) for the 2011 and 2018 cohort, respectively. There were improvements in presentation to blood draw (163-90 min, p<0.001). Time from presentation to first ECG actually increased (16.2 vs 31.2 min, p<0.001). Analysis of hs-cTn values and ECGs revealed a maximum ED discharge rate of 69%, by applying the 0/3-hour protocol, implying potential for increasing safe ED discharge.

CONCLUSIONS:

Implementation of an ADP with hs-cTn is safe and effective for early rule-out and discharge of suspected ACS but require considerable resources and education to optimise maximal patient flow.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiologia / Síndrome Coronariana Aguda / Infarto do Miocárdio Limite: Humans Idioma: En Revista: Open Heart Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiologia / Síndrome Coronariana Aguda / Infarto do Miocárdio Limite: Humans Idioma: En Revista: Open Heart Ano de publicação: 2023 Tipo de documento: Article